{"transactions":[{"id":2428517,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T16:15:24.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":340000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 19, 2022 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2022, subject to continued service."}],"balance_after":340000,"derivative":{"exercise_price":12.69,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0000899243-22-002879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000089924322002879/doc4.xml","form_type":"4"}},{"id":2604954,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-12T16:20:48.000Z","date":"2021-08-11","kind":"exercise","acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on December 18, 2018 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of December 18, 2018. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service."}],"balance_after":243571,"derivative":{"exercise_price":7.84,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0000899243-21-032753","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000089924321032753/doc4.xml","form_type":"4"}},{"id":2604953,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-12T16:20:48.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on December 18, 2018 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of December 18, 2018. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service."}],"balance_after":271571,"derivative":{"exercise_price":7.84,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0000899243-21-032753","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000089924321032753/doc4.xml","form_type":"4"}},{"id":2604952,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-12T16:20:48.000Z","date":"2021-08-11","kind":"sale","acquired":false,"shares":28000,"price":23.75,"value":665000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-032753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000089924321032753/doc4.xml","form_type":"4"}},{"id":2604951,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-12T16:20:48.000Z","date":"2021-08-11","kind":"exercise","acquired":true,"shares":28000,"price":7.84,"value":219520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."}],"balance_after":28000,"source":{"system":"sec-edgar","filing":"0000899243-21-032753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000089924321032753/doc4.xml","form_type":"4"}},{"id":2604950,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-12T16:20:48.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":32000,"price":17.5,"value":560000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-032753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000089924321032753/doc4.xml","form_type":"4"}},{"id":2604949,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-12T16:20:48.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":32000,"price":7.84,"value":250880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."}],"balance_after":32000,"source":{"system":"sec-edgar","filing":"0000899243-21-032753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000089924321032753/doc4.xml","form_type":"4"}},{"id":2760368,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-02T16:30:29.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 31, 2021 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of March 31, 2021, subject to continued service."}],"balance_after":350000,"derivative":{"exercise_price":11.78,"expiration_date":"2031-03-30","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000899243-21-014592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000089924321014592/doc4.xml","form_type":"4"}},{"id":2893160,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-27T16:30:16.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":134376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 25, 2021 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2021, subject to continued service."}],"balance_after":134376,"derivative":{"exercise_price":13.09,"expiration_date":"2031-01-24","underlying":"Common Stock","underlying_shares":134376},"source":{"system":"sec-edgar","filing":"0000899243-21-003474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000089924321003474/doc4.xml","form_type":"4"}},{"id":3301069,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-27T16:31:27.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 23, 2020 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2020, subject to continued service."}],"balance_after":105000,"derivative":{"exercise_price":16.87,"expiration_date":"2030-01-22","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0000899243-20-002041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000089924320002041/doc4.xml","form_type":"4"}},{"id":3458964,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":131168,"kind":"person","name":"Stuart Bryan","position":1,"cik":"0001619846","reported_name":"Stuart Bryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-18T17:26:36.000Z","date":"2019-07-18","kind":"grant","acquired":true,"shares":28571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on July 18, 2019. The shares underlying the option are scheduled to vest in equal quarterly installments from July 1, 2019 through June 30, 2023."}],"balance_after":28571,"derivative":{"exercise_price":16,"expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":28571},"source":{"system":"sec-edgar","filing":"0001104659-19-040966","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619846/000110465919040966/a4.xml","form_type":"4"}}]}